(0.11%) 5 244.75 points
(0.13%) 39 589 points
(0.10%) 18 233 points
(0.77%) $79.87
(1.13%) $2.33
(1.04%) $2 364.60
(1.18%) $28.70
(0.47%) $995.50
(0.02%) $0.928
(-0.20%) $10.84
(-0.03%) $0.798
(-0.59%) $92.00
-4.26% $ 20.00
@ $18.60
Emitido: 14 feb 2024 @ 12:04
Retorno: 7.53%
Señal anterior: feb 13 - 14:56
Señal anterior:
Retorno: 2.65 %
Live Chart Being Loaded With Signals
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial...
Stats | |
---|---|
Volumen de hoy | 1.01M |
Volumen promedio | 737 664 |
Capitalización de mercado | 1.87B |
EPS | $0 ( 2024-05-09 ) |
Próxima fecha de ganancias | ( $-0.390 ) 2024-06-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -12.74 |
ATR14 | $0.0420 (0.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-06 | Morris Arlene | Buy | 34 311 | Stock Options (Right to buy) |
2024-05-06 | Morris Arlene | Buy | 0 | |
2024-05-01 | Moore John R | Sell | 5 208 | Restricted Stock Units |
2024-05-01 | Moore John R | Buy | 5 208 | Common Stock |
2024-05-02 | Moore John R | Sell | 1 956 | Common Stock |
INSIDER POWER |
---|
71.74 |
Last 96 transactions |
Buy: 6 453 320 | Sell: 592 683 |
Volumen Correlación
Edgewise Therapeutics, Correlación
10 Correlaciones Más Positivas | |
---|---|
HCCI | 0.952 |
FFNW | 0.949 |
DSPG | 0.939 |
STAY | 0.923 |
TLGT | 0.915 |
ISRG | 0.911 |
TIL | 0.911 |
SRTS | 0.909 |
FSEA | 0.908 |
SUMO | 0.906 |
10 Correlaciones Más Negativas | |
---|---|
MMAC | -0.947 |
RNAZ | -0.944 |
CNSP | -0.933 |
NETE | -0.928 |
UXIN | -0.927 |
XPDI | -0.922 |
WINT | -0.916 |
AXDX | -0.913 |
SCPS | -0.911 |
CSSEN | -0.91 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Edgewise Therapeutics, Correlación - Moneda/Commodity
Edgewise Therapeutics, Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.73M (0.00 %) |
EPS: | $-1.570 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.73M (0.00 %) |
EPS: | $-1.570 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-538 000 (0.00 %) |
EPS: | $-0.290 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.140 |
Financial Reports:
No articles found.
Edgewise Therapeutics,
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico